Periscope: Unsuccessful on Nasdaq, GenSight finds a home on Paris exchange
Paris-based GenSight would likely have been met with open arms on Nasdaq if it had filed for an IPO when biotech offerings and gene therapies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
